Skip to main content
. 2018 Aug 17;43(3):180–184. doi: 10.1080/01658107.2018.1506938

Table 1.

Patient demographics and findings.

Pt. Sex Age Past medical history Visual symptoms Visual field Visual acuity Outcome
1 F 59 HTN, DM, HLP, obesity, MS, DVT Diplopia NA 20/40 OU Full resolution
2 M 58 HTN, DM, HLP, obesity, OSA, COPD OU vision loss OS superior loss 20/50 OD, 20/200 OS Full resolution
3 F 31 HTN, OSA OS photopsias NA 20/20 OU Full resolution
4 M 27 HTN, CKD, PE, endocarditis, IVDU OU vision loss Full OU 20/20 OU Full resolution
5 F 58 HTN Diplopia, colour desaturation NA NA Full resolution
6 M 50 HTN, HLP, CKD, glaucoma, anaemia OU vision loss NA NA Full resolution
7 M 37 HTN OS vision loss, OS pain with EOMs Full OU 20/20 OD, 20/40 OS Full resolution
8 F 7 HTN OU vision loss Full OU CF OU Full resolution
9 F 62 HTN, COPD, anaemia OU vision loss Left lower quadrantanopia NA Full resolution
10 F 53 HTN, HLP, CAD, CVA OU vision loss NA NA Full resolution
11 F 62 HTN, epilepsy, recurrent PRES OU vision loss, diplopia OU diffuse depression LP Intermittent binocular diplopia

PT, patient; F, female; HTN, hypertension; DM, diabetes mellitus; HLP, hyperlipidaemia; MS, multiple sclerosis; DVT, deep vein thrombosis; NA, not assessed; OU, right and left eyes; M, male; OSA, obstructive sleep apnoea; COPD, chronic obstructive sleep apnoea; OS, left eye; OD, right eye; CKD, chronic kidney disease; PE, pulmonary embolism; IVDU, intravenous drug use; EOMs, extraocular muscle movements; CF, counting fingers; PRES, posterior reversible encephalopathy syndrome; LP, light perception; CAD, coronary artery disease; CVA, cerebrovascular accident.